Stay updated on ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    No significant changes detected between the two page states; only minor visual differences are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:12:52.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:16:13.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:19:19.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    - Updated page revision from v3.0.0 to v3.0.2. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-13T17:36:57.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new therapeutic techniques and the removal of specific disease-related resources and terms.
    Difference
    2%
    Check dated 2025-08-30T11:39:20.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:29:25.000Z thumbnail image

Stay in the know with updates to ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.